Lantheus Holdings (LNTH) EBT Margin (QoQ) (2014 - 2026)
Lantheus Holdings (LNTH) EBT Margin (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.39 Bn | 43.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.04 Bn | 2.15 Bn |
| 3 | Zoetis | 32.28 Bn | 30.60 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn |
| 6 | Viatris | 18.94 Bn | 18.06 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.94 Bn | 11.41 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | Lantheus Holdings | 6.53 Bn | 5.94 Bn | 241.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1,728.00 |
| Mar 31, 2026 | 2,256.00 |
| Dec 31, 2025 | 785.00 |
| Sep 30, 2025 | -1,661.00 |
| Jun 30, 2025 | 175.00 |
| Mar 31, 2025 | 13,601.00 |
| Dec 31, 2024 | -15,662.00 |
| Sep 30, 2024 | 2,509.00 |
| Jun 30, 2024 | -2,488.00 |
| Mar 31, 2024 | -87,639.00 |
| Dec 31, 2023 | 87,269.00 |
| Sep 30, 2023 | 1,155.00 |
| Jun 30, 2023 | 4,214.00 |
| Mar 31, 2023 | 6,328.00 |
| Dec 31, 2022 | -10,166.00 |
| Sep 30, 2022 | 696.00 |
| Jun 30, 2022 | 1.00 |
| Mar 31, 2022 | 5,937.00 |
| Dec 31, 2021 | -1,222.00 |
| Sep 30, 2021 | 880.00 |